Weight loss · El Paso, TX
Weight loss and obesity studies in El Paso, TX
6 recruiting studies have a site in El Paso.
6 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Eli Lilly and Company
- Location
- El Paso, TX + 68 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Novo Nordisk A/S
- Location
- El Paso, TX + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Amgen
- Location
- El Paso, TX + 69 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Novo Nordisk A/S
- Location
- El Paso, TX + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Improving Glycemic Control With Electrical Stimulation
University of Texas, El Paso
- Location
- El Paso, TX
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism
University of Texas, El Paso
- Location
- El Paso, TX
- Eligibility basics
- Ages 18–65
Who these studies look for
Most of these studies set a BMI range and may exclude people taking certain weight-loss medicines or who have had bariatric surgery. Some require a weight-related condition such as type 2 diabetes or high blood pressure.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.